LIN9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.735200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.370000E-01
Normal-vs-Stage2
4.109600E-01
Normal-vs-Stage3
5.667800E-01
Normal-vs-Stage4
3.566400E-01
Stage1-vs-Stage2
9.425800E-01
Stage1-vs-Stage3
2.407400E-01
Stage1-vs-Stage4
6.583400E-01
Stage2-vs-Stage3
1.750250E-01
Stage2-vs-Stage4
4.291000E-01
Stage3-vs-Stage4
2.462200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.913600E-01
Normal-vs-AfricanAmerican
3.158000E-01
Normal-vs-Asian
4.475200E-01
Caucasian-vs-AfricanAmerican
8.039600E-01
Caucasian-vs-Asian
6.148200E-01
AfricanAmerican-vs-Asian
9.185400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.548600E-01
Normal-vs-Female
5.034000E-01
Male-vs-Female
4.872000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.762600E-01
Normal-vs-Age(41-60Yrs)
4.466000E-01
Normal-vs-Age(61-80Yrs)
4.745200E-01
Normal-vs-Age(81-100Yrs)
1.903790E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.337600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.698200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.374600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.843400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.721200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.363200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.157600E-01
Normal-vs-Daily Drinker
8.344600E-01
Normal-vs-Weekly Drinker
6.439000E-01
Normal-vs-Occasional Drinker
3.230200E-01
Normal-vs-Social Drinker
4.665800E-01
Non Drinker-vs-Daily Drinker
1.664370E-01
Non Drinker-vs-Weekly Drinker
4.267800E-01
Non Drinker-vs-Occasional Drinker
7.832400E-01
Non Drinker-vs-Social Drinker
7.579600E-01
Daily Drinker-vs-Weekly Drinker
6.675200E-01
Daily Drinker-vs-Occasional Drinker
1.194650E-01
Daily Drinker-vs-Social Drinker
3.433200E-01
Weekly Drinker-vs-Occasional Drinker
3.113600E-01
Weekly Drinker-vs-Social Drinker
6.342400E-01
Occasional Drinker-vs-Social Drinker
5.856400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.278800E-01
Normal-vs-Grade 2
1.708970E-01
Normal-vs-Grade 3
1.141580E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.692320E-02
Grade 1-vs-Grade 3
2.820400E-03
Grade 1-vs-Grade 4
5.278800E-01
Grade 2-vs-Grade 3
1.879230E-01
Grade 2-vs-Grade 4
1.708970E-01
Grade 3-vs-Grade 4
1.141580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.061400E-01
Normal-vs-NonDiabetic
4.402000E-01
Diabetic-vs-NonDiabetic
8.350300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.992400E-01
Normal-vs-NoPancreatitis
5.077000E-01
Pancreatitis-vs-NoPancreatitis
5.648800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.839200E-01
Normal-vs-N1
4.304200E-01
N0-vs-N1
8.046800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.519700E-02
Normal-vs-TP53-NonMutant
4.330800E-01
TP53-Mutant-vs-TP53-NonMutant
1.164520E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
